SLC16A1 and myeloid sarcoma: Moreover, they can impair the metabolic support of axons through downregulation of the oligodendroglial monocarboxylate transporter 1 (MCT1) [9] or lead to an accumulation of nitrosylated protein residues in MS lesions, such as 3-nitrotyrosine [10,11].